Literature DB >> 21845360

[Molecular diagnosis of HPV infections].

N Wentzensen1.   

Abstract

Carcinogenic human papillomaviruses (HPV) cause the majority of cervical cancers and other anogenital cancers. Large randomized trials have shown that HPV testing can be efficiently used for primary cervical cancer screening. Other applications include the triage of abnormal cytology results and the follow-up of women after treatment. Many assays have been developed to measure DNA, RNA and proteins of HPV and the various tests can have very different applications. It is important to rigorously validate HPV assays before they are implemented in screening or clinical care.

Entities:  

Mesh:

Year:  2011        PMID: 21845360      PMCID: PMC4237608          DOI: 10.1007/s00292-011-1475-6

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  26 in total

1.  The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability.

Authors:  Stefan Duensing; Karl Münger
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

Review 2.  Chapter 2: The burden of HPV-related cancers.

Authors:  D Maxwell Parkin; Freddie Bray
Journal:  Vaccine       Date:  2006-08-31       Impact factor: 3.641

3.  Carcinogenicity of human papillomaviruses.

Authors:  Vincent Cogliano; Robert Baan; Kurt Straif; Yann Grosse; Béatrice Secretan; Fatiha El Ghissassi
Journal:  Lancet Oncol       Date:  2005-04       Impact factor: 41.316

Review 4.  Human papillomavirus testing in the prevention of cervical cancer.

Authors:  Mark Schiffman; Nicolas Wentzensen; Sholom Wacholder; Walter Kinney; Julia C Gage; Philip E Castle
Journal:  J Natl Cancer Inst       Date:  2011-01-31       Impact factor: 13.506

5.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

6.  A study of the impact of adding HPV types to cervical cancer screening and triage tests.

Authors:  Mark Schiffman; Michelle J Khan; Diane Solomon; Rolando Herrero; Sholom Wacholder; Allan Hildesheim; Ana Cecilia Rodriguez; Maria C Bratti; Cosette M Wheeler; Robert D Burk
Journal:  J Natl Cancer Inst       Date:  2005-01-19       Impact factor: 13.506

Review 7.  Molecular diagnosis of human papillomavirus (HPV) infections.

Authors:  Anco Molijn; Berhard Kleter; Wim Quint; Leen-Jan van Doorn
Journal:  J Clin Virol       Date:  2005-03       Impact factor: 3.168

Review 8.  HPV detection methods.

Authors:  Antoinette A T P Brink; Peter J F Snijders; Chris J L M Meijer
Journal:  Dis Markers       Date:  2007       Impact factor: 3.434

Review 9.  Papillomavirus life cycle organization and biomarker selection.

Authors:  John Doorbar
Journal:  Dis Markers       Date:  2007       Impact factor: 3.434

Review 10.  Biomarkers in cervical cancer screening.

Authors:  Nicolas Wentzensen; Magnus von Knebel Doeberitz
Journal:  Dis Markers       Date:  2007       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.